openPR Logo
Press release

Neurotrophic Keratitis Market demonstrates a spectacular growth by 2027 according to new research report

06-13-2019 10:50 AM CET | Health & Medicine

Press release from: Credence Research

Neurotrophic Keratitis Market demonstrates a spectacular

The latest market report published by Credence Research, Inc. “Global neurotrophic keratitis Market - Growth, Future Prospects, Competitive Analysis, 2019- 2027,” the global neurotrophic keratitis market is expected to expand at a CAGR of 5.2% from 2019 to 2027.

Market Insights
Ophthalmologist are currently employing the healing pathway of nerve growth factor (NGF) which is a neurotrophin that initiates neuronal sprouting by injured and intact neurons, a landmark discovery made by R. Levi Montalcini a nobel laureate. The human cornea produces high affinity NGF receptors which plays an important role in stimulating both survival and proliferation of epithelial and nerve fibres. Oxervate follows this pathway to treat neurotrophic keratitis across all age group.

Neurotrophic keratitis is an orphan disease with a global prevalence rate of 5 per 10,000 people. It is manifested by the damage of trigeminal nucleus nerve innervations present in the eye corneal region which dampens the healing process of corneal injuries. The treatment approach is adopted as per the different stages of the disease. Artificial tears are recommended in all the phases to ensure wetness, cleanliness and lubrication of the corneal surface. Topical antibiotics are prescribed in the stage 2 of the disease as a preventive measure against bacterial infection. In stage 3 surgical procedures such as Tarsorraphy, and amniotic membrane transplantation are preferred to treat corneal ulcers. Recent approval of Oxervate a recombinant human nerve growth factor by EMA and USFDA will bolster the neurotrophic market growth during the forecast period.

Browse the full report Neurotrophic Keratitis Market - Growth, Future Prospects, Competitive Analysis, 2019 – 2027 report at https://www.credenceresearch.com/report/neurotrophic-keratitis-market

North America is responsible for 33% market share and is currently the largest regional segment in neurotrophic keratitis market. As per the research findings brought forward by the American Academy of Ophthalmology (AAO), approximately 65,000 U.S. citizens are reported to be suffering with neurotrophic keratitis. Affordable reimbursement scenario propels the neurotrophic keratitis market growth in North America region. Europe trails North America and accounts for 28.5% market growth primarily due to strategic collaboration between academic research institute and pharmaceutical giants to develop novel drugs for the treatment of neurotrophic keratitis. European Medical Agency (EMA) has awarded orphan disease status to neurotrophic keratitis and has expedited its drug development and sale propaganda in the EU market. Asia Pacific holds 16% market share owing to the rising prevalence of neurotrophic keratitis in geriatric population and rampant growth in ophthalmology in the region over the last decade.
Pharmaceutical companies specializing in providing medication for the treatment of neurotrophic keratitis are Allergan, Plc., Abbott Laboratories, Inc., Bausch & Lomb Incorporated, Bayer AG, CooperVision, Dompe farmaceutici S.p.A., Johnson & Johnson, Novartis AG, ReGenTree, LLC., and Walgreens.

Key Market Movements:
• Rising prevalence of neurotrophic keratitis worldwide
• Supportive regulatory scenario provided for the growth of neurotrophic keratitis market by the healthcare agencies throughout the globe
• Recent approval by EMA and priority review designation awarded by the USFDA will help to flourish the Oxervate market for the treatment of neurotrophic keratitis in North America and Europe

Full Report: https://www.credenceresearch.com/sample-request/59723

Medium: https://medium.com/@CredenceResearc/neurotrophic-keratitis-market-north-america-is-responsible-for-33-market-share-432cd8d4f1ac

Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free (US/CANADA): +1-800-361-8290
Email: sales@credenceresearch.com

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurotrophic Keratitis Market demonstrates a spectacular growth by 2027 according to new research report here

News-ID: 1773156 • Views:

More Releases from Credence Research

Lipase Testing Reagents Market Projected to Hit USD 2049.8 Million by 2032, Expanding at 6.9% CAGR: Credence Research
Lipase Testing Reagents Market Projected to Hit USD 2049.8 Million by 2032, Expa …
Market Outlook The Lipase Testing Reagents Market is experiencing robust growth, driven by increasing demand for reliable pancreatic function assessment across hospitals, diagnostic laboratories, and point-of-care settings. Rising screening rates for acute pancreatitis and metabolic disorders continue to support wider reagent adoption globally. Additionally, advancements in clinical chemistry analyzers are boosting the use of high-precision, stable lipase reagents in routine diagnostic workflows. The market was valued at USD 1,202 million in
Content Analytics Market Projected to Hit USD 35,833.20 Million by 2032, Expanding at 18.48 % CAGR: Credence Research
Content Analytics Market Projected to Hit USD 35,833.20 Million by 2032, Expandi …
Market Outlook The content analytics market is experiencing robust expansion as enterprises increasingly depend on data-driven insights to improve customer engagement, optimize operations, and accelerate decision-making. Global demand continues to rise with the growing adoption of AI-powered text, speech, and video analytics across industries. In 2024, the market reached USD 9,274.38 million and is projected to grow to USD 35,833.20 million by 2032, reflecting a strong CAGR of 18.48% throughout the
Crawler Excavator Market Projected to Hit USD 64,819.48 Million by 2032, Expanding at 2.92% CAGR: Credence Research
Crawler Excavator Market Projected to Hit USD 64,819.48 Million by 2032, Expandi …
Market Outlook The global Crawler Excavator Market reached USD 51,605.17 million in 2024 and is expected to hit USD 64,819.48 million by 2032, growing at a CAGR of 2.92%. Growth comes from steady infrastructure spending, rapid city redevelopment, and rising mining and quarrying activity. Many governments continue to fund road, rail, and utility upgrades, which increases the need for high-capacity earthmoving machines. Crawler excavators stay popular because they offer strong stability,
Digital Mining Market Projected to Hit USD 16,471.08 Million by 2032, Expanding at 9.17% CAGR: Credence Research
Digital Mining Market Projected to Hit USD 16,471.08 Million by 2032, Expanding …
Market Outlook The Digital Mining Market, valued at USD 8,229.51 million in 2024, is set for substantial growth as mining companies increasingly adopt automation, data-driven operations, and connected equipment. Key technologies, including AI-enabled analytics, autonomous haulage systems, IoT-based fleet monitoring, and advanced geological modeling, are enhancing productivity, minimizing downtime, and improving worker safety. Mining enterprises are also leveraging digital twins, cloud-based planning tools, and predictive maintenance systems to optimize extraction and

All 5 Releases


More Releases for Neurotrophic

Top Market Shifts Transforming the Neurotrophic Keratitis Treatment Market Lands …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Neurotrophic Keratitis Treatment Market Through 2025? The valuation of the neurotrophic keratitis treatment sphere has experienced rapid expansion lately, projected to escalate from a figure of $1.08 billion in 2024 to $1.47 billion by 2025, reflecting a substantial compound annual growth rate
Neurotrophic Keratitis Patient Pool Analysis Market Forecast to Grow at 8.2% CAG …
Introduction Neurotrophic keratitis (NK) is a rare, degenerative corneal disease caused by impaired corneal innervation, leading to reduced or absent corneal sensitivity. This results in poor wound healing, epithelial breakdown, and in severe cases, corneal ulceration, scarring, and vision loss. Although classified as a rare disease, NK has a significant clinical impact due to its association with conditions such as herpes simplex virus (HSV) keratitis, herpes zoster ophthalmicus, diabetes, ocular surgeries,
Neurotrophic Keratitis Treatment Market Landscape 2025: Forecast Data and Growth …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts What Is the Expected CAGR for the Neurotrophic Keratitis Treatment Market Through 2025? The market size for treatment of neurotrophic keratitis has experienced robust growth in the last few years. The market, which was valued at $5.1 billion in 2024, is expected to reach $5.51 billion in 2025, reflecting
Key Neurotrophic Keratitis Treatment Market Trend for 2025-2034: Innovative Drug …
What Is the Future Outlook for the Neurotrophic Keratitis Treatment Market's Size and Growth Rate? The neurotrophic keratitis treatment market has experienced robust growth in recent years. It is forecasted to grow from $5.1 billion in 2024 to $5.51 billion in 2025, at a CAGR of 8.1%. Historical growth has been influenced by increased diagnoses, a rising number of injuries and surgical procedures, ongoing research and development efforts, and improvements in
Advances in Neurotrophic Keratitis Treatment: Breakthroughs and Innovations
Neurotrophic keratitis is a rare and neurodegenerative disease that affects the cornea of an eye. This disease leads to reduction or loss of cornea sensitivity. It further leads to ulcer formation and ultimately corneal perforation. Increase in special designation from the regulatory authorities is a major factor fostering the growth of the market. Rising expenditure on the development of healthcare infrastructure and upsurge in the demand for novel therapies and treatment
Neurotrophic Keratitis Market Growth Set to Surge Significantly during 2019 - 20 …
Neurotrophic Keratitis Market: Introduction Transparency Market Research has published a new report titled, "Global Neurotrophic Keratitis Market". According to the report, the global neurotrophic keratitis market was valued at US$ 91.6 Mn in 2018 and is projected to expand at a CAGR of ~17% from 2019 to 2027. Rise in reported cases of keratitis, increase in research & developmental activities, surge in awareness, and rise in co-morbidities & risk factors boost